UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000054955 |
|---|---|
| Receipt number | R000062787 |
| Scientific Title | Survey on the Willingness to Pay (WTP) for Oral Antivirals for COVID-19 |
| Date of disclosure of the study information | 2024/07/12 |
| Last modified on | 2026/01/13 17:51:40 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Survey on the Willingness to Pay (WTP) for Oral Antivirals for COVID-19
Acronym
Survey on the Willingness to Pay (WTP) for Oral Antivirals for COVID-19
Scientific Title
Survey on the Willingness to Pay (WTP) for Oral Antivirals for COVID-19
Scientific Title:Acronym
Survey on the Willingness to Pay (WTP) for Oral Antivirals for COVID-19
Region
| Japan |
Condition
Condition
COVID-19
Classification by specialty
| Medicine in general | Pneumology | Infectious disease |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Evaluate the monetary value of the function of Oral Antivirals for COVID-19 that prevent transmission to others.
Basic objectives2
Others
Basic objectives -Others
Not applicable
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Average Willingness to Pay (WTP) adjusted for the population distribution among Japanese individuals.
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 75 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Not applicable
Key exclusion criteria
Not applicable
Target sample size
3000
Research contact person
Name of lead principal investigator
| 1st name | Masahiro |
| Middle name | |
| Last name | Kinoshita |
Organization
Shionogi & Co., Ltd.
Division name
Medical Affairs
Zip code
5410045
Address
1-8, Dosho-machi 3-chome, Chuo-ku, Osaka
TEL
08024670790
masahiro.kinoshita@shionogi.co.jp
Public contact
Name of contact person
| 1st name | Kenji |
| Middle name | |
| Last name | Kurazono |
Organization
Shionogi & Co., Ltd.
Division name
Medical Affairs
Zip code
5410045
Address
1-8, Dosho-machi 3-chome, Chuo-ku, Osaka
TEL
08053647605
Homepage URL
kenji.kurazono@shionogi.co.jp
Sponsor or person
Institute
Shionogi & Co., Ltd.
Institute
Department
Personal name
Funding Source
Organization
Shionogi & Co., Ltd.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Health Outcome Research Institute
Address
1-23-26-400, Ichikawa, Ichikawa City, Chiba
Tel
-
info@hor-i.org
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2024 | Year | 07 | Month | 12 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
3131
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2024 | Year | 04 | Month | 02 | Day |
Date of IRB
| 2024 | Year | 04 | Month | 15 | Day |
Anticipated trial start date
| 2024 | Year | 05 | Month | 17 | Day |
Last follow-up date
| 2024 | Year | 05 | Month | 23 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
| 2024 | Year | 07 | Month | 13 | Day |
Other
Other related information
questionnaire survey(cross-sectional study)
Management information
Registered date
| 2024 | Year | 07 | Month | 12 | Day |
Last modified on
| 2026 | Year | 01 | Month | 13 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062787
